Tesamorelin

Growth hormone releasing hormone analog.

Tesamorelin is a GHRH analog that stimulates the pituitary to release growth hormone. This is a compounded preparation and is not an FDA-approved product.

How it works

Tesamorelin acts on pituitary GHRH receptors to stimulate growth hormone release, with particular efficacy for reducing visceral adipose tissue and improving metabolic markers.

Benefits

• Visceral fat reduction
• Natural GH stimulation
• Improved body composition
• Cognitive support
• Lipid profile improvement

Dosing protocol

2mg subcutaneous injection daily, preferably at bedtime.

Contraindications

• Active malignancy
• Pregnancy
• Hypersensitivity to tesamorelin or mannitol

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.